“. . . The fraud case is prerequisite to the patent case . . . .”   I. INTRODUCTION   In mid-June 2025, attorneys for plaintiffs Janssen Products and PharmaMar were reviewing their opponent’s document production in a routine Hatch-Waxman patent case when they stumbled across something that shouldn't exist: their own clients' highly confidential regulatory filings . Not summaries. Not publicly available information. But instead, substantive portions of the proprietary specific

“The math is stark: infringement victory + validity win + $10 million jury award = $1, if you cannot apportion value to the patented...

“The Federal Circuit did not mince words about Phillips's litigation strategy, describing it as ‘sandbagging’ Magēmā with a...